Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
- 29 July 2014
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 29 (8) , 1629-1636
Abstract
Background and Aims: Acute exacerbation (AE) of chronic hepatitis B virus (HBV) infection is common and negatively impacts the clinical outcome. Although upsurge of viral load always precedes or coincides with AE, the underlying immunological mechanisms remain unclear and were investigated.Methods: We prospectively followed the serum cytokine/chemokine profiles, viral load, and alanine aminotransferase (ALT) levels in 250 patients and identified 44 consecutive patients (male: 72.7%; age: 40.4 ± 9.7 years; hepatitis B e antigen [HBeAg] positivity: 63.6%; genotype B/C: 75%/25%) who developed AE during the follow‐up in a medical center. The impact of clinical characteristics (age, gender, HBeAg, ALT, HBV genotype), cytokines (tumor necrosis factor‐alpha, interferon gamma, interleukin [IL]‐2, IL‐4, IL‐6, and IL‐10), and chemokines (CXCL10/interferon gamma‐induced protein [IP]‐10, CCL2/MCP‐1, CXCL9/MIG, CCL5/RANTES, and CXCL8/IL‐8) on the serum HBV DNA dynamics at different time points (baseline, peak of serum HBV DNA level, peak of serum ALT level, and after AE) were analyzed.Results: Of 44 patients, serum HBV DNA level surged before the peak of serum ALT level in 23 (52.3%), and coincided with the peak of ALT in 21 (47.7%). The upsurge of serum viral load significantly correlated with the increase of IL‐10 (P = 0.0037) and CXCL10/IP‐10 (P = 0.0044). Upsurge of serum viral load was preceded by an increase in serum IL‐4 (P < 0.05), IL‐6 (P < 0.05), and IL‐10 (P < 0.05). Combination of HBV genotype, IL‐6 level at baseline, and ALT level at the peak of serum HBV DNA reliably predicted subsequent AE pattern (P = 0.0116).Conclusions: Enhanced Th2 activity is likely involved in the surge of HBV DNA level before hepatitis exacerbation.Keywords
Funding Information
- National Science Council (NSC94-3112-B002-023, NSC95-3112-B002-009, NSC96-3112-B-002-009, NSC97-3112-B002-025, NSC98-3112-B002-018)
- Department of Health, Executive Yuan, Taiwan
- National Taiwan University Hospital, Taiwan
This publication has 34 references indexed in Scilit:
- Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 2006
- Resolution of a chronic viral infection after interleukin-10 receptor blockadeJournal of Experimental Medicine, 2006
- Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisJournal of Hepatology, 2004
- Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramersImmunology Letters, 2004
- Long–Term Interleukin 10 Therapy in Chronic Hepatitis C Patients Has A Proviral and Anti–Inflammatory EffectHepatology, 2003
- Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequencesHepatology, 2001
- A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patientsJournal of Viral Hepatitis, 2001
- Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionScience, 1999
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus.Gut, 1994